MIR4783

Across TCGA pan-cancer cohorts, MIR4783 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR4783 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher MIR4783 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4783 expression acts as an unfavorable survival marker, although some lineages such as PAAD and KIRP show a favorable association.

CHOL, MESO, and COAD are the cancer types where MIR4783 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Median	III,IV	0.286	1.000	.008	33	view →
MESO	OS	Quartile	II,III,IV	0.254	0.442	.007	32	view →
COAD	OS	Tertile	All	0.346	0.602	.012	24	view →
PCPG	OS	Tertile	All	0.888	1.000	.002	18	view →
BRCA	DFS	Tertile	All	0.850	0.909	.010	15	view →
THCA	DFS	Tertile	II,III,IV	0.762	0.878	.037	15	view →
PAAD	DFS	Median	All	0.443	0.275	.008	14	view →
UCEC	OS	Tertile	II,III,IV	0.737	0.860	.036	12	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
SARC	OS	Tertile	All	0.451	0.780	.004	9	view →
KIRP	DFS	Median	II,III,IV	0.791	0.566	.015	8	view →
KICH	DFS	Tertile	All	0.445	0.856	.032	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR4783–CHOL (OS)

Open the CHOL breakdown →